New medicines for treating tuberculosis, malaria and other infectious diseases are still urgently needed, particularly in developing countries. The spread of antibiotic-resistant germs also results in a critical...
The Scientific Director of the Helmholtz Centre for Infection Research (HZI), Prof Dirk Heinz, the President of Saarland University, Prof Manfred Schmitt, the Managing Director of the Helmholtz Institute for...
Professor Rolf Müller ist mit der Ehrendoktorwürde der Shandong University in China ausgezeichnet worden. Die chinesische Partneruniversität würdigte damit die herausragenden Leistungen von Rolf Müller in der...
Their ideas fight complicated urinary tract infections, ensure sustainable natural resource exploration and supply, and answer previously unanswered questions concerning nephrology and gynecology: Three Helmholtz...
We live our everyday lives together with countless microbes and viruses that could also infect us. The immune system prevents many attacks, but it needs our cooperation: Proper hygiene and regular vaccinations...
The CRISPR-Cas technology can be used to precisely edit DNA. Originally, it is a viral defense mechanism of bacteria. The CRISPR-Cas systems currently in use in biotechnology are classified as class II. They are...
Mikroben und ihr Vorkommen stehen im Fokus der Veranstaltungsreihe „KrankheitsErregend“ des Helmholtz-Zentrums für Infektionsforschung (HZI). In diesem Jahr findet die Reihe in Kooperation mit dem Haus der Wissenschaft...
Jörg Vogel, founding director of the Helmholtz Institute for RNA-based Infection Research (HIRI) and director of the Institute for Molecular Infection Biology (IMIB) at the Julius-Maximilians-Universität Würzburg (JMU),...
Last week, the Budget Committee of the Lower House of the German Parliament (Bundestag) decided to provide 40 million euros in funding for the establishment of a possible new Helmholtz Institute in Greifswald, spread...